{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:41:48Z","timestamp":1788871308147,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"In Vitro Drug Safety and Biotechnology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.clinbiochem.2013.07.003","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T20:31:53Z","timestamp":1373920313000},"page":"1532-1537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Valproic acid derivatives signal for apoptosis and repair in vitro"],"prefix":"10.1016","volume":"46","author":[{"given":"Manuela G.","family":"Neuman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu M.","family":"Nanau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfeeq","family":"Shekh-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Yagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","article-title":"Valproic acid: second generation","volume":"4","author":"Bialer","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","article-title":"Valproic acid as a promising agent to combat Alzheimer's disease","volume":"81","author":"Zhang","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0025","first-page":"(CD004028)","article-title":"Valproate for schizophrenia","volume":"3","author":"Schwarz","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2009.02.027","article-title":"Status epilepticus: a critical review","volume":"15","author":"Knake","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0022-3859.81807","article-title":"Status epilepticus: why, what, and how","volume":"57","author":"Nair","year":"2011","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2012.11.005","article-title":"A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus","volume":"231","author":"Pouliot","year":"2013","journal-title":"Neuroscience"},{"issue":"Suppl. 2","key":"10.1016\/j.clinbiochem.2013.07.003_bb0050","first-page":"S41","article-title":"Recent developments in treatment of status epilepticus: a review","volume":"4","author":"Rosenow","year":"2002","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","article-title":"Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study","volume":"18","author":"Chen","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs. phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0075","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0883073807306248","article-title":"Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial","volume":"22","author":"Mehta","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.seizure.2009.11.007","article-title":"Management of refractory status epilepticus at a tertiary care centre in a developing country","volume":"19","author":"Tripathi","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0090","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0095","series-title":"The liver. An atlas of ultrastructural pathology","first-page":"159","author":"Phillips","year":"1987"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0100","series-title":"Drug-induced hepatotoxicity","first-page":"637","article-title":"Antiepileptic drugs","author":"Zimmerman","year":"1996"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(01)00217-X","article-title":"CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity","volume":"34","author":"Neuman","year":"2001","journal-title":"Clin Biochem"},{"issue":"Suppl. 2","key":"10.1016\/j.clinbiochem.2013.07.003_bb0110","first-page":"S23","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/01480540903207076","article-title":"Drugs interfering with mitochondrial disorders","volume":"33","author":"Finsterer","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.seizure.2012.03.003","article-title":"Epilepsy in mitochondrial disorders","volume":"21","author":"Finsterer","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425255.2012.644535","article-title":"Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders","volume":"8","author":"Finsterer","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0130","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1021\/jm901229s","article-title":"Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues","volume":"52","author":"Kaufmann","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2011.03338.x","article-title":"A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage","volume":"53","author":"White","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0016-5085(98)70377-4","article-title":"Role of cytokines in ethanol-induced cytotoxicity in vitro in HepG2 cells","volume":"115","author":"Neuman","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9120(00)00146-6","article-title":"A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes","volume":"33","author":"Neuman","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0150","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1025069519218","article-title":"Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy","volume":"20","author":"Isoherranen","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.bjp.0706310","article-title":"Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain","volume":"146","author":"Winkler","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0160","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neuropharm.2010.03.004","article-title":"Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid","volume":"58","author":"Kaufmann","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0165","first-page":"85","article-title":"Valproate-associated hepatotoxicity and its biochemical mechanisms","volume":"3","author":"Eadie","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1528-1157.1993.tb02419.x","article-title":"Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity","volume":"34","author":"Siemes","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1528-1157.1988.tb03758.x","article-title":"Valproate metabolites and hepatotoxicity in an epileptic population","volume":"29","author":"Tennison","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","article-title":"Fatal liver failure in 16 children with valproate therapy","volume":"29","author":"Scheffner","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0006-2952(99)00108-2","article-title":"Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha: implication for valproic acid-associated hepatotoxicity syndrome","volume":"58","author":"Yao","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0148607198022005286","article-title":"TNF-alpha and IL-6 synergistically inhibit ketogenesis from fatty acids and alpha-ketoisocaproate in isolated rat hepatocytes","volume":"22","author":"Pailla","year":"1998","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/157488606777934459","article-title":"Antiepileptic drug-induced hypersensitivity syndrome reactions mechanisms","volume":"1","author":"Krivoy","year":"2006","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0205","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(85)91481-3","article-title":"Valproic acid associated abnormalities of carnitine metabolism","volume":"1","author":"Murphy","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00315032","article-title":"Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects","volume":"38","author":"Bialer","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.07.003_bb0215","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0009-9236(97)90194-6","article-title":"Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy","volume":"61","author":"Barel","year":"1997","journal-title":"Pharmacol Ther"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:08:46Z","timestamp":1762114126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013003366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":43,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0009912013003366"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.07.003","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid derivatives signal for apoptosis and repair in vitro","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}